Question 1

Who are the top researchers at Apexigen (United States)?

Accepted Answer

Ranked on the quality score, Erin L. Filbert and Xiaodong Yang lead among researchers whose main affiliation is Apexigen (United States).

Question 2

What are the most cited papers from Apexigen (United States)?

Accepted Answer

The most cited paper from Apexigen (United States) is "Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial" (Lacey Padrón et al., 2022), with 381 citations. Next come "CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study" (311) and "NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023" (213).

Question 3

Which research topics does Apexigen (United States) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses and Libraries and Information Services.

Question 4

Which keywords describe research at Apexigen (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Antigen Presentation, Dendritic Cells, Glycosylation, Immunotherapy, Tumor Microenvironment and Monoclonal Antibodies.

Question 5

Which fields of science does Apexigen (United States) work in?

Accepted Answer

In all years, 42% of research at Apexigen (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Medicine (36%), Immunology and Microbiology (34%), Biochemistry, Genetics and Molecular Biology (9%). It does 1.9× the world's share of Life Sciences.

Question 6

Is Apexigen (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 18% higher than in 2018-2021.